Rethinking the AAP Attention Deficit/Hyperactivity Disorder Guidelines

American Academy of Pediatrics . Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033-1044.

American Academy of Pediatrics . Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000;105:1158-1170.

Baughman FA . Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder (Letter). Pediatrics. 2000;106:1239-1240.

Practice parameter for the use of stimulant medication in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41:2(supplement):26S-49S.

McGuiness D . Attention deficit disorder: the emperor’s clothes, animal “pharm,” and other fiction. In: Fisher S , Greenburg RP , eds. The Limits of Biological Treatments for Psychological Distress. Hillsdale, NJ: Lawrence Erbaum Associates; 1989:151-187.

Furman RA . Attention deficit/hyperactivity disorder: an alternative viewpoint. J Int Child Adolesc Psychiatry. 2002;2:125-144.

Weinberg WA , Brumback WA . The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurol. 1992;7:431-435.

El-Sayed E , Larsson JO , Persson HE , et al. “Maturational lag” hypothesis of attention deficit/hyperactivity disorder: an update. Acta Pediatr. 2003;92:776-784.

Carey WB . Is attention deficit hyperactivity a valid disorder? Invited presentation to the NIH Consensus Development Conference on ADHD, November 16-18, 1998, National Institutes of Health, Bethesda, MD.

Coles G . The Learning Mystique. New York: Pantheon Books; 1987.

Drug Enforcement Administration, Office of Public Affairs . Methylphenidate and Amphetamine Yearly Production Quota (1980-2000). Washington, DC: Department of Justice; 2001.

Drug Enforcement Administration, Office of Diversion Control . Methylphenidate. A background paper. Washington, DC, Department of Justice, October 1995.

Furman RA . Methylphenidate and “ADHD” in Europe and the United States. Child Analysis. 1996;7:132-145.

Rappaport JL , Buchsbaum MS , Weingartner H , et al. Dextroamphetamine. Cognitive and behavioral effects in normal prepubertal boys. Science. 1978;199:560-563.

Rappaport JL , Buchsbaum MS , Weingartner H , et al. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and men. Arch Gen Psychiatry. 1980;37:933-943.

Bernstein GA , Carroll ME , Crosby RD , et al. Caffeine effects on learning, performance and anxiety in normal school-age children. J Am Acad Child Adolesc Psychiatry. 1994;33:407-415.

Zito JM , Safer DJ , dosReis S , et al. Trends in the prescribing of psychotropic medication to preschoolers. JAMA. 2000;283:1025-1030.

Diller L . Lessons from three year olds. Dev Behav Pediatr. 2002;23:S10-S12.

Fraser KM . Too young for attention deficit disorder? Views from preschool. Dev Behav Pediatr. 2002;23:S46-S50.

Pozzi ME . Ritalin for whom? J Child Psychotherapy. 2000;26:25-43.

Jacobvitz D , Sroufe LA . The early care-giver child relationship and attention deficit disorder with hyperactivity in kindergarten: a prospective study. Child Dev. 1987;58:1488-1495.